New Products


For more information, call 866-DERM-001 (337-6001) or visit the company's Web site at http://

Menopause screening tests for home and office Menocheck, an over-the-counter, one-step, at-home menopause indicator test, is now available at pharmacies nationwide. Similar to a home pregnancy test, the convenient midstream wand device is a noninvasive alternative to clinical blood testing for initial screenings. The product works by measuring urinary FSH, which usually rises gradually once menopause begins.

The agency based its approval on findings from four double-blind, 12-week, randomized, placebo-controlled, parallel-group multicenter trials involving more than 3,000 patients who had symptoms of urgency, frequency, and/or urge incontinence. In all four studies, the efficacy of once-daily administration of 5 or 10 mg of VESIcare was consistent across patient age and gender. The most common side effects were dry mouth (5 mg, 10.9%; 10 mg, 27.6% vs. placebo, 4.2%), constipation (5 mg, 5.4%; 10 mg, 13.4% vs. placebo, 2.9%), and blurred vision (5 mg, 3.8%; 10 mg, 4.8% vs. placebo, 1.8%). As with other anticholinergic agents, VESIcare is contraindicated in patients with urinary retention, gastric retention, and uncontrolled narrow-angle glaucoma.

The drug-which is now available in the US-is co-promoted by GlaxoSmithKline and Yamanouchi Pharmaceutical Co., Ltd. For more information, visit http://

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
© 2024 MJH Life Sciences

All rights reserved.